Anas Gazzah

7.9k citations
99 papers · 2.1k indexed · h-index 22
Topics
Lung Cancer Treatments and Mutations (34 papers)Cancer Immunotherapy and Biomarkers (30 papers)Cancer Genomics and Diagnostics (15 papers)
Partner nations
FranceSpainUnited States

In The Last Decade

Anas Gazzah

90 papers receiving 2.0k citations

Peers

Anas Gazzah
Comparison fields: 5 of 84
  • Oncology 1.3k
  • Pulmonary and Respiratory Medicine 861
  • Molecular Biology 553
  • Cancer Research 355
  • Immunology 305
Replace Wael A. Harb with:
Wael A. Harb United States
María Alsina Spain
Kimio Yonesaka Japan
Kai Li China
Yusri Elsayed United States
Laura Mezquita France
Bradley A. McGregor United States
Thomas Powles United Kingdom
Tania Fleitas Spain
Ryosuke Okamura Japan
Anas Gazzah relative to Wael A. Harb United States Wael A. Harb's profile →
Citations per field
00.5×1.7×
Wael A. Harb · 1×
Citations per year

Countries citing papers authored by Anas Gazzah

Since Specialization
Citations

This map shows the geographic impact of Anas Gazzah's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anas Gazzah with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anas Gazzah more than expected).

Fields of papers citing papers by Anas Gazzah

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Anas Gazzah. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anas Gazzah. The network helps show where Anas Gazzah may publish in the future.

Co-authorship network of co-authors of Anas Gazzah

This figure shows the co-authorship network connecting the top 25 collaborators of Anas Gazzah. A scholar is included among the top collaborators of Anas Gazzah based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Anas Gazzah. Anas Gazzah is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 0
2 1
3 1
4 1
5 9
6 4
7 2
8 15
9 1
10 1
11 3
12 53
13 5
14 1
15 106
16 0
17 20
18 133
19 12
20 16

About Anas Gazzah

Anas Gazzah is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Cancer Research, having authored 99 papers that have together received 2.1k indexed citations. Recurring topics across this work include Lung Cancer Treatments and Mutations (34 papers), Cancer Immunotherapy and Biomarkers (30 papers) and Cancer Genomics and Diagnostics (15 papers). The work is most often cited by research in Oncology (1.3k citations), Pulmonary and Respiratory Medicine (861 citations) and Cancer Research (355 citations). Anas Gazzah has collaborated with scholars based in France, Spain and United States. Frequent co-authors include Jean‐Charles Soria, Benjamin Besse, David Planchard, Caroline Caramella, Aurélien Marabelle, Laura Mezquita, Christophe Massard, Antoine Hollebecque, Rastislav Bahleda and Andréa Varga. Their work appears in journals such as Journal of Clinical Oncology, Blood and Cancer Research.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026